H. Pralle

Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group [see comments]

Rüdiger Hehlmann, H. Heimpel, Joerg Hasford et al. · Blood · 1994 · 458 citations · Full text

Medicine, Hematology, Oncology +10

Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia

Rüdiger Hehlmann, Michael Lauseker, Susanne Jung-Munkwitz et al. · Journal of Clinical Oncology · 2011 · 323 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +12

Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group

Rüdiger Hehlmann, H. Heimpel, Joerg Hasford et al. · Blood · 1993 · 207 citations · Full text

Medicine, Hematology, Oncology +11

Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: Anthracycline does not improve the prognosis

P. Meusers, M. Engelhard, H. Bartels et al. · Hematological Oncology · 1989 · 172 citations

Medicine, Oncology, Pharmacology +16

Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

Richard F Schlenk, Stefan Fröhling, Frank Hartmann et al. · Leukemia · 2004 · 170 citations

Medicine, Hematology, Oncology +5